Viral and host factors related to the clinical outcome of COVID-19
By Xiaonan Zhang, Yun Tan, Y. Ling, G. Lu, Feng Liu, Zhigang Yi, Xiaofang Jia, Min Wu, Bisheng Shi, Shuibao Xu and 15 more. Nature, 2020
834 citations recorded by the source corpus.
Subfields: Infectious Diseases, Neurology
View Paper: https://www.semanticscholar.org/paper/94ca55796d88a39c1d26a5a3ac4d6bc34815f3a9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- B. Gallo Marin
- Ghazal Aghagoli
- Bruce D. Walker
- Katya Lavine
- Lanbo Yang
- Emily J. Siff
- S. Chiang
- P. Kaplonek
Citations in the corpus
- The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 (2020, neutral): “The main contributing features explaining this difference included IL8 (Figure 2B), a chemokine recently shown to be associated with lymphopenia in severe COVID-19 cases (Zhang et al., 2020).”
- Severe Covid-19. (2020, background): “[18] Severe COVID-19 has been associated with a cytokine release storm largely related to the ACE-2.”
- Predictors of COVID-19 severity: A literature review (2020, background): “2 The precise determinants of severe disease are not known, but it appears that primarily host factors rather than viral genetic mutations drive the pathogenesis.(3) However, emerging data from a non-peer-reviewed”
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19 (2020, positive): “, 2020) and the degree of lymphopenia has been correlated with increases in circulating interleukin-6 (IL-6) and IL-8 (Zhang et al., 2020).”